- Ionis Pharmaceuticals ( NASDAQ: IONS ) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, before market open.
- The consensus EPS Estimate is -$0.86 (-161.0% Y/Y) and the consensus Revenue Estimate is $160.21M (-63.6% Y/Y).
- Over the last 1 year, IONS has beaten EPS estimates 25% of the time and has beaten revenue estimates 25% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 3 upward revisions and 4 downward.
For further details see:
Ionis Pharmaceuticals Q4 2022 Earnings Preview